Vertex Pharmaceuticals (VRTX) Gains from Investment Securities (2016 - 2026)
Quarterly Gains from Investment Securities fell 5.66% to $5.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Mar 2026, up 21067.57% year-over-year, with the annual reading at $1.6 billion for FY2025, 4562.8% up from the prior year.
Vertex Pharmaceuticals' Gains from Investment Securities history spans 18 years, with the latest figure at $5.0 million for Q1 2026.
- Gains from Investment Securities came in at $5.0 million for Q1 2026, down from $389.4 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.2 billion in Q3 2025 to a low of -$874.2 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $4.3 million (2025), against an average of $103.6 million.
- Year-over-year, Gains from Investment Securities crashed 3175.0% in 2022 and then soared 389133.33% in 2025.
- Vertex Pharmaceuticals' Gains from Investment Securities stood at $982.7 million in 2022, then plummeted by 188.96% to -$874.2 million in 2023, then surged by 100.15% to $1.3 million in 2024, then surged by 29853.85% to $389.4 million in 2025, then crashed by 98.72% to $5.0 million in 2026.
- Per Business Quant, the three most recent readings for VRTX's Gains from Investment Securities are $5.0 million (Q1 2026), $389.4 million (Q4 2025), and $1.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 389.40 Mn |
| Dec 31, 2025 | 389.40 Mn |
| Sep 30, 2025 | 1.17 Bn |
| Sep 30, 2025 | 1.17 Bn |
| Jun 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 34.80 Mn |
| Mar 31, 2024 | 34.80 Mn |
| Dec 31, 2023 | -874.20 Mn |
| Dec 31, 2023 | -874.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | -600,000.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | 10.60 Mn |
| Mar 31, 2023 | 10.60 Mn |
| Dec 31, 2022 | 982.70 Mn |
| Dec 31, 2022 | 982.70 Mn |
| Sep 30, 2022 | -2.60 Mn |
| Sep 30, 2022 | -2.60 Mn |
| Jun 30, 2022 | -49.20 Mn |
| Jun 30, 2022 | -49.20 Mn |
| Mar 31, 2022 | 85.00 Mn |
| Mar 31, 2022 | 85.00 Mn |
| Dec 31, 2021 | 156.40 Mn |
| Dec 31, 2021 | 156.40 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.60 Mn |
| Mar 31, 2021 | -3.90 Mn |
| Mar 31, 2021 | -3.90 Mn |
| Dec 31, 2020 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 1.80 Mn |
| Sep 30, 2020 | 1.80 Mn |
| Jun 30, 2020 | 9.20 Mn |
| Jun 30, 2020 | 9.20 Mn |
| Mar 31, 2020 | 1.60 Mn |
| Mar 31, 2020 | 1.60 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 2.96 Mn |
| Sep 30, 2019 | 2.96 Mn |
| Dec 31, 2018 | -43.90 Mn |
| Dec 31, 2018 | -43.90 Mn |
| Jun 30, 2018 | 12.90 Mn |
| Jun 30, 2018 | 12.90 Mn |
| Mar 31, 2018 | -5.83 Mn |
| Mar 31, 2018 | -5.83 Mn |
| Sep 30, 2017 | -69.60 Mn |
| Sep 30, 2017 | -69.60 Mn |
| Jun 30, 2017 | 1.05 Mn |
| Jun 30, 2017 | 1.05 Mn |
| Mar 31, 2017 | 1.16 Mn |
| Mar 31, 2017 | 1.16 Mn |
| Dec 31, 2016 | 61,000.00 |
| Dec 31, 2016 | 61,000.00 |
| Sep 30, 2016 | 100,000.00 |
| Sep 30, 2016 | 100,000.00 |
| Jun 30, 2016 | -4.02 Mn |
| Jun 30, 2016 | -4.02 Mn |